POET Technologies: A $400 Million Production Bet Overshadowed by a June 29 Courtroom Clock

Extreme volatility has become the defining characteristic of POET Technologies, with shares lurching between double-digit gains and deep sell-offs as two opposing narratives play out. On Friday, the stock surged nearly 12% to €10.88, but the rally does little to disperse the legal clouds hanging over the photonics firm. Annualized volatility now exceeds 200%, leaving investors whipsawed by the twin forces of a massive capital injection and an impending class-action deadline.

The legal troubles trace back to late April, when Marvell Semiconductor abruptly canceled all orders from POET’s subsidiary Celestial AI, citing a breach of confidentiality. The disclosure triggered a single-day collapse of more than 47% in the stock price. Several U.S. law firms have since launched efforts to assemble a securities class action, accusing management of misleading statements—including misrepresenting the company’s tax status as a passive foreign investment vehicle. A lead plaintiff must be named by June 29, a date that now looms as a major catalyst for the share price.

Management is fighting back on both fronts. The board has decided to relocate the corporate headquarters to the United States, which would eliminate the controversial tax classification. POET has also clarified that it expects no tax liabilities for U.S. shareholders in fiscal 2025 given its accumulated losses. On the operational side, the company secured roughly $400 million in gross proceeds from a single institutional investor in May. The funds are earmarked for manufacturing infrastructure and research, directly addressing the capital needs exposed by the latest quarterly report: revenue rose to just over half a million dollars, but the net loss stood at $12.3 million.

Should investors sell immediately? Or is it worth buying POET Technologies?

There are bright spots beyond the balance sheet. In May, POET signed a supply agreement with Lumilens initially valued at $50 million, with the potential for substantially higher revenue over the long term. The contract underscores demand for optical chips in artificial-intelligence data centers—a market POET hopes will convert into recurring orders. Yet the stock remains far from its 52-week high of €18.84, and on a monthly basis it is still down more than 11%.

Chart watchers note that the shares are holding above the 50-day moving average of €9.49, but the June 29 deadline keeps legal risk front and center. Despite a year-to-date gain of nearly 78%, the path forward hinges on whether the looming class action proves less damaging than feared. If it does, investor attention could shift back to the production ramp and the potential of AI-driven optics—but until then, the volatility is unlikely to subside.